MILESTONE PHARMACEUTICALS IN's ticker is MIST and the CUSIP is 59935V107. A total of 28 filers reported holding MILESTONE PHARMACEUTICALS IN in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $53,604 | +69.3% | 17,293 | +55.6% | 0.00% | – |
| Q2 2023 | $31,668 | -20.4% | 11,113 | +10.1% | 0.00% | – |
| Q1 2023 | $39,779 | +261.6% | 10,097 | +250.0% | 0.00% | – |
| Q4 2022 | $11,000 | -54.2% | 2,885 | +10.9% | 0.00% | – |
| Q3 2022 | $24,000 | +33.3% | 2,602 | -9.6% | 0.00% | – |
| Q2 2022 | $18,000 | 0.0% | 2,879 | 0.0% | 0.00% | – |
| Q1 2022 | $18,000 | +5.9% | 2,879 | +14.2% | 0.00% | – |
| Q4 2021 | $17,000 | +70.0% | 2,520 | +39.1% | 0.00% | – |
| Q3 2021 | $10,000 | +25.0% | 1,811 | +23.0% | 0.00% | – |
| Q2 2021 | $8,000 | +166.7% | 1,472 | +144.9% | 0.00% | – |
| Q1 2021 | $3,000 | – | 601 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ikarian Capital, LLC | 1,750,043 | $11,464,000 | 1.71% |
| Novo Holdings A/S | 2,530,585 | $16,575,000 | 0.78% |
| Boxer Capital, LLC | 2,238,861 | $14,665,000 | 0.57% |
| RTW INVESTMENTS, LP | 4,315,102 | $28,264,000 | 0.41% |
| RA Capital Management | 2,246,503 | $14,715,000 | 0.26% |
| Bleichroeder LP | 250,000 | $1,638,000 | 0.26% |
| PURA VIDA INVESTMENTS, LLC | 931,511 | $6,101,000 | 0.22% |
| Orbimed Advisors | 2,583,821 | $16,924,000 | 0.22% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 851,291 | $5,576,000 | 0.11% |
| Eversept Partners, LP | 147,165 | $963,931 | 0.06% |